-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on TransMedics Group, Lowers Price Target to $120

Benzinga·05/06/2026 19:48:03
Listen to the news
TD Cowen analyst Joshua Jennings maintains TransMedics Group (NASDAQ:TMDX) with a Buy and lowers the price target from $190 to $120.